These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23444618)
21. Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves. Craig TM; Huey RL Am J Vet Res; 1984 Aug; 45(8):1644-5. PubMed ID: 6476577 [TBL] [Abstract][Full Text] [Related]
22. Acute and subacute Fasciolosis of alpacas (Lama pacos) and treatment with triclabendazole. Puente GL Trop Anim Health Prod; 1997 Feb; 29(1):31-2. PubMed ID: 9090014 [No Abstract] [Full Text] [Related]
23. Hepatic fascioliasis: case report and review. Abdul-Hadi S; Contreras R; Tombazzi C; Alvarez M; Melendez M Rev Inst Med Trop Sao Paulo; 1996; 38(1):69-73. PubMed ID: 8762643 [TBL] [Abstract][Full Text] [Related]
24. Human fascioliasis. Saba R; Korkmaz M; Inan D; Mamikoğlu L; Turhan O; Günseren F; Cevikol C; Kabaalioğlu A Clin Microbiol Infect; 2004 May; 10(5):385-7. PubMed ID: 15113313 [TBL] [Abstract][Full Text] [Related]
25. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep. Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107 [TBL] [Abstract][Full Text] [Related]
26. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Hien TT; Truong NT; Minh NH; Dat HD; Dung NT; Hue NT; Dung TK; Tuan PQ; Campbell JI; Farrar JJ; Day JN Am J Trop Med Hyg; 2008 Mar; 78(3):388-92. PubMed ID: 18337331 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland. Sargison ND; Scott PR Vet Rec; 2011 Feb; 168(6):159. PubMed ID: 21493511 [TBL] [Abstract][Full Text] [Related]
28. A case of human fasciolosis: discrepancy between egg size and genotype of Fasciola sp. Inoue K; Kanemasa H; Inoue K; Matsumoto M; Kajita Y; Mitsufuji S; Kataoka K; Okanoue T; Yamada M; Uchikawa R; Tegoshi T; Arizono N Parasitol Res; 2007 Feb; 100(3):665-7. PubMed ID: 17102984 [TBL] [Abstract][Full Text] [Related]
29. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole. Fawcett AR Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087 [TBL] [Abstract][Full Text] [Related]
30. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep. Novobilský A; Averpil HB; Höglund J Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198 [TBL] [Abstract][Full Text] [Related]
31. [Stomach ache and fever after consumption of watercress in Turkey: fascioliasis]. van Daele PL; Madretsma GS; van Agtmael MA Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1896-9. PubMed ID: 11605314 [TBL] [Abstract][Full Text] [Related]
32. Cervical tumor caused by the sexually mature stage of Fasciola hepatica. Marcos LA; Légua P; Sánchez J; Espinoza JR; Yi P; Tantaleán M Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):318-20. PubMed ID: 19046753 [TBL] [Abstract][Full Text] [Related]
33. [Fascioliasis after a stay in Turkey]. Metter K; Glöser H; von Gaisberg U Dtsch Med Wochenschr; 2000 Sep; 125(39):1160-3. PubMed ID: 11075243 [TBL] [Abstract][Full Text] [Related]
34. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Marcos LA; Tagle M; Terashima A; Bussalleu A; Ramirez C; Carrasco C; Valdez L; Huerta-Mercado J; Freedman DO; Vinetz JM; Gotuzzo E Am J Trop Med Hyg; 2008 Feb; 78(2):222-7. PubMed ID: 18256419 [TBL] [Abstract][Full Text] [Related]
36. [Hepatic distomatosis due to Fasciola hepatica. Considerations apropos of 2 cases]. Bleiberg H; Bremer A; Thys O; Remacle P; Mainguet P Acta Gastroenterol Belg; 1969; 32(4-5):396-404. PubMed ID: 5403059 [No Abstract] [Full Text] [Related]
37. A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature. Karahocagil MK; Akdeniz H; Sunnetcioglu M; Cicek M; Mete R; Akman N; Ceylan E; Karsen H; Yapici K Acta Trop; 2011 Jun; 118(3):177-83. PubMed ID: 18930014 [TBL] [Abstract][Full Text] [Related]
39. Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E). Rehim WM; Sharaf IA; Hishmat M; el-Toukhy MA; Rawash NA; Fouad HN Arzneimittelforschung; 2003; 53(3):214-20. PubMed ID: 12705178 [TBL] [Abstract][Full Text] [Related]
40. Triclabendazole resistance involving Fasciola hepatica in sheep and goats during an outbreak in Almirante Tamandare, Paraná, Brazil. Oliveira DR; Ferreira DM; Stival CC; Romero F; Cavagnolli F; Kloss A; Araújo FB; Molento MB Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():149-53. PubMed ID: 20059835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]